A novel outpatient regimen in management of fluoropyrimidine-induced cardiotoxicity.

Anup KasiPramod GaudelManidhar LekkalaRaed Al-RajabiAnwaar SaeedWeijing SunCharles Porter

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

Utilizing our novel outpatient regimen, we have successfully and safely allowed re-challenge of FP chemotherapy with good tolerability and completion of the intended course of chemotherapy without recurrent morbidity.

Keyphrases

locally advanced
high glucose
open label
diabetic rats
drug induced
clinical trial
chemotherapy induced
radiation therapy